Peer Review reports
From: The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma
| Original Submission | ||
|---|---|---|
| 3 Nov 2014 | Submitted | Original manuscript |
| Author responded | Author comments | |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Author responded | Author comments | |
| Reviewed | Reviewer Report | |
| Reviewed | Reviewer Report | |
| Reviewed | Reviewer Report | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Author responded | Author comments | |
| Reviewed | Reviewer Report | |
| Reviewed | Reviewer Report | |
| Reviewed | Reviewer Report | |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 31 Mar 2015 | Editorially accepted | |
| 18 Apr 2015 | Article published | 10.1186/s12885-015-1302-1 |
You can find further information about peer review here.